APPY : Summary for Venaxis, Inc. - Yahoo Finance

U.S. Markets closed

Venaxis, Inc. (APPY)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.94-0.01 (-0.25%)
At close: 4:00 PM EST
People also watch:
ABIOCYCCOPXAACURBIOD
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close3.95
Open3.76
Bid3.30 x 800
Ask4.10 x 700
Day's Range3.62 - 4.04
52 Week Range1.60 - 6.65
Volume115,780
Avg. Volume83,076
Market Cap17.75M
Beta2.89
PE Ratio (TTM)-3.11
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswireyesterday

    Venaxis Reports Name Change to Bioptix, Inc and NASDAQ Ticker Symbol Change to "BIOP" from "APPY"

    BOULDER, Colo., Dec. 8, 2016 /PRNewswire/ --  Venaxis®, Inc. (Nasdaq: APPY), announced that following the approval from shareholders at the 2016 Annual Meeting of Shareholders of the proposal to change ...

  • Venaxis, Inc. :APPY-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016
    Capital Cube21 days ago

    Venaxis, Inc. :APPY-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016

    Categories: Yahoo Finance Get free summary analysis Venaxis, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Venaxis, Inc. – Vermillion, Inc., Chembio Diagnostics, Inc., OraSure Technologies, Inc., Alere Inc., Echo Therapeutics, Inc., American Bio Medica Corporation and Myriad Genetics, Inc. (VRML-US, CEMI-US, OSUR-US, ALR-US, ECTE-US, ... Read more (Read more...)

  • PR Newswire3 months ago

    Venaxis Reports Option Inducement Grants for New Employees Under NASDAQ Listing Rule 5635(c)(4)

    CASTLE ROCK, Colo., Sept. 23, 2016 /PRNewswire/ -- Venaxis®, Inc. (APPY), announced that on September 21, 2016, the Company approved the grant of stock options to six new employees, hired in connection with the Company's acquisition of BiOptix Diagnostics, Inc., to purchase an aggregate of 95,000 shares of common stock. The stock options were granted as inducement grants material to the new employees entering into employment with the Company, as permitted under NASDAQ Listing Rule 5635(c)(4).